Home » Authors » Karen Carey

Articles by Karen Carey

Cypress Licenses Collegium's Patent Portfolio For Milnacipran

Jan. 27, 2004

Inex Partners Lead Drug With Enzon; Launch Expected 2005

Jan. 21, 2004

One year before a potential launch, Inex Pharmaceuticals Corp. found a North American partner - Enzon Pharmaceuticals Inc. - for its cancer drug Onco TCS. (BioWorld Today)

ILEX Drops Bladder Cancer Drug After Phase III Failure

Jan. 20, 2004

ILEX Oncology Inc.'s drug eflornithine (DFMO) failed to reach statistical significance in a Phase III trial with superficial bladder cancer patients, resulting in the company's decision to discontinue development. (BioWorld Today)

NovaScreen Signs Biodefense Contract On Immune Boosters

Jan. 16, 2004

TargeGen's Series B Brings In $30M For AMI, Cancer Programs

Jan. 16, 2004

Enanta Raises $12M To Further Macrolide Respiratory Program

Jan. 15, 2004

BioStratum Could Receive $80M Per Antibody In Novo Cancer Deal

Jan. 14, 2004

Acumen, Merck Sign Alzheimer's Disease Pact With $96M Potential

Jan. 14, 2004

Concurrent Raises $15M, Partners With Intel On 'Machine Learning'

Jan. 13, 2004

$19M Private Placement Ranks As Cortex's 'Biggest Financing'

Jan. 12, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...